{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:19:06Z","timestamp":1761718746068,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007515","name":"University of Valladolid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007515","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007515","name":"University of Valladolid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.breast.2018.11.010","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T05:34:25Z","timestamp":1543469665000},"page":"91-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer"],"prefix":"10.1016","volume":"43","author":[{"given":"Carolina","family":"Vel\u00e1zquez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva M.","family":"Esteban-Carde\u00f1osa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Lastra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis E.","family":"Abella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"de la Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen D.","family":"Lobat\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar","family":"Infante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2018.11.010_bib1","article-title":"Exploring the roles of PALB2 at the crossroads of DNA repair and cancer","volume":"461","author":"Pauty","year":"2014","journal-title":"Biochem J"},{"key":"10.1016\/j.breast.2018.11.010_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091886","article-title":"The role of PALB2 in the DNA damage response and cancer predisposition","volume":"18","author":"Nepomuceno","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.breast.2018.11.010_bib3","first-page":"423","article-title":"Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges","volume":"50","author":"Poumpouridou","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.breast.2018.11.010_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12920-017-0251-8","article-title":"PALB2 mutations in BRCA1\/2-mutation negative breast and ovarian cancer patients from Poland","volume":"10","author":"Kluska","year":"2017","journal-title":"BMC Med Genom"},{"key":"10.1016\/j.breast.2018.11.010_bib5","doi-asserted-by":"crossref","first-page":"e67538","DOI":"10.1371\/journal.pone.0067538","article-title":"Analysis of PALB2 gene in BRCA1\/BRCA2 negative Spanish hereditary breast\/ovarian cancer families with pancreatic cancer cases","volume":"8","author":"Blanco","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.breast.2018.11.010_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10549-011-1842-2","article-title":"Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer","volume":"132","author":"Blanco","year":"2012","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.breast.2018.11.010_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Nicola Waddel","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.breast.2018.11.010_bib8","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.breast.2018.11.010_bib9","first-page":"263","article-title":"PALB2: the Hub of a network of tumor suppressors involved in DNA damage responses","volume":"1846","author":"Park","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.breast.2018.11.010_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nprot.2006.482","article-title":"Heteroduplex analysis by capillary array electrophoresis for rapid mutation detection in large multiexon genes","volume":"2","author":"Velasco","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.breast.2018.11.010_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10549-008-0036-z","article-title":"The prevalence of PALB2 germline mutations in BRCA1\/BRCA2 negative Chinese women with early onset breast cancer or affected relatives","volume":"114","author":"Cao","year":"2009","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.breast.2018.11.010_bib12","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1073\/pnas.0701724104","article-title":"Analysis of PALB2\/FANCN-associated breast cancer families","volume":"104","author":"Tischkowitz","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.breast.2018.11.010_bib13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature05609","article-title":"A\u00a0recurrent mutation in PALB2 in Finnish cancer families","volume":"446","author":"Erkko","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.breast.2018.11.010_bib14","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1186\/bcr3392","article-title":"Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families","volume":"15","author":"Teo","year":"2013","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2018.11.010_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2018.11.010_bib16","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1186\/bcr2832","article-title":"Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1\/2-founder mutation-negative breast and\/or ovarian cancer individuals","volume":"13","author":"Kuusisto","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2018.11.010_bib17","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/nsmb.1915","article-title":"Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination","volume":"17","author":"Buisson","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.breast.2018.11.010_bib18","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1242\/jcs.060178","article-title":"MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks","volume":"123","author":"Hayakawa","year":"2010","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.breast.2018.11.010_bib19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/jhg.2010.112","article-title":"Mutation analysis of the gene encoding the PALB2-binding protein MRG15 in BRCA1\/2-negative breast cancer families","volume":"55","author":"Frio","year":"2010","journal-title":"J\u00a0Hum Genet"},{"key":"10.1016\/j.breast.2018.11.010_bib20","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1038\/onc.2013.421","article-title":"Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair","volume":"33","author":"Park","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.breast.2018.11.010_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13058-016-0762-9","article-title":"The PALB2\u00a0p.Leu939Trp mutation is not associated with breast cancer risk","volume":"18","author":"Catucci","year":"2016","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2018.11.010_bib22","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1073\/pnas.1620208114","article-title":"MRG15-mediated tethering of PALB2 to unperturbed chromatin protects active genes from genotoxic stress","volume":"114","author":"Bleuyard","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.breast.2018.11.010_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/pbc.25201","article-title":"Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing Program: PALB2 mutation predicts exceptional in\u00a0vivo response to BMN 673","volume":"62","author":"Smith","year":"2015","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.breast.2018.11.010_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-8-24","article-title":"CHK1 inhibition as a strategy for targeting fanconi anemia (FA) DNA repair pathway deficient tumors","volume":"8","author":"Chen","year":"2009","journal-title":"Mol Canc"},{"key":"10.1016\/j.breast.2018.11.010_bib25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977618303278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977618303278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:40:20Z","timestamp":1760776820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977618303278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":25,"alternative-id":["S0960977618303278"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2018.11.010","relation":{},"ISSN":["0960-9776"],"issn-type":[{"type":"print","value":"0960-9776"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2018.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}